Healthcare provider profile · identity verified

Michael James Sass, D.O.

Internal Medicine · DANVILLE, PA · NPI 1992157960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	411	156
Omeprazole	Omeprazole	263	90
Lisinopril	Lisinopril	243	90
Levothyroxine Sodium	Levothyroxine Sodium	209	74
Gabapentin	Gabapentin	200	63
Rosuvastatin Calcium	Rosuvastatin Calcium	179	67
Amlodipine Besylate	Amlodipine Besylate	155	68
Metoprolol Succinate	Metoprolol Succinate	145	46
Losartan Potassium	Losartan Potassium	133	47
Albuterol Sulfate Hfa	Albuterol Sulfate	122	48
Tamsulosin Hcl	Tamsulosin Hcl	119	40
Metformin Hcl Er	Metformin Hcl	114	45
Fluticasone Propionate	Fluticasone Propionate	103	41
Pregabalin	Pregabalin	102	24
Sertraline Hcl	Sertraline Hcl	101	33
Duloxetine Hcl	Duloxetine Hcl	99	33
Furosemide	Furosemide	99	36
Famotidine	Famotidine	97	38
Metoprolol Tartrate	Metoprolol Tartrate	94	23
Hydrochlorothiazide	Hydrochlorothiazide	90	40
Pantoprazole Sodium	Pantoprazole Sodium	90	29
Simvastatin	Simvastatin	84	23
Montelukast Sodium	Montelukast Sodium	80	29
Metformin Hcl	Metformin Hcl	78	27
Citalopram Hbr	Citalopram Hydrobromide	76	19
Trazodone Hcl	Trazodone Hcl	73	21
Prednisone	Prednisone	72	64
Tramadol Hcl	Tramadol Hcl	70	17
Ozempic	Semaglutide	68	16
Eliquis	Apixaban	65	22
Jardiance	Empagliflozin	60	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	suppressed
Clonazepam	Clonazepam	52	suppressed
Clopidogrel	Clopidogrel Bisulfate	52	23
Warfarin Sodium	Warfarin Sodium	51	20
Ezetimibe	Ezetimibe	50	16
Alprazolam	Alprazolam	45	suppressed
Levetiracetam	Levetiracetam	43	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	16
Potassium Chloride	Potassium Chloride	42	15
Lorazepam	Lorazepam	41	12
Tizanidine Hcl	Tizanidine Hcl	41	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	39	17
Oxycodone Hcl	Oxycodone Hcl	39	15
Alendronate Sodium	Alendronate Sodium	38	11
Buspirone Hcl	Buspirone Hcl	37	12
Breo Ellipta	Fluticasone/Vilanterol	36	12
Doxycycline Hyclate	Doxycycline Hyclate	36	27
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	12
Methocarbamol	Methocarbamol	36	13
Mounjaro	Tirzepatide	36	suppressed
Allopurinol	Allopurinol	35	15
Baclofen	Baclofen	35	12
Carvedilol	Carvedilol	34	13
Bupropion Xl	Bupropion Hcl	32	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	15
Glipizide Er	Glipizide	32	14
Finasteride	Finasteride	31	11
Ondansetron Odt	Ondansetron	29	suppressed
Atenolol	Atenolol	28	15
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	11
Synthroid	Levothyroxine Sodium	27	suppressed
Myrbetriq	Mirabegron	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Linzess	Linaclotide	23	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	23	20
Lansoprazole	Lansoprazole	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Azithromycin	Azithromycin	20	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Torsemide	Torsemide	20	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	16	16
Clonidine Hcl	Clonidine Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Etodolac	Etodolac	14	suppressed
Fluconazole	Fluconazole	14	11
Methadone Hcl	Methadone Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Topiramate Er	Topiramate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Topiramate	Topiramate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Diazepam	Diazepam	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error